AL
OSIR

AJO LP’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

AJO LP’s Portfolio OSIR Stock Details OSIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-13,910
Closed -$271K – 592
2015
Q2 		$271K Buy
+13,910
New +$246K ﹤0.01% 496

Other funds holding OSIR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

AJO LP's OSIR Position: Q3 2015 in Review

AJO LP sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q3 2015, closing a stake of 13,910 shares — an estimated $271K sold.

AJO LP first reported a position in OSIR in Q2 2015 and held it in 1 quarter. The position peaked at $271K in Q2 2015. 92 funds tracked by Wall St. Rank hold OSIR as of Q3 2015.

  • AJO LP reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q3 2015 after selling out during the quarter.
  • AJO LP sold 13,910 Osiris Therapeutics, Inc. Common Stock shares in Q3 2015, an estimated $271K.
  • AJO LP first reported a position in Osiris Therapeutics, Inc. Common Stock in Q2 2015 and held it in 1 quarter.
  • AJO LP's Osiris Therapeutics, Inc. Common Stock position peaked at $271K in Q2 2015.
  • 92 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q3 2015.

Based on AJO LP's 13F filing for Q3 2015, filed 13 Nov 2015.